Market Update: Regeneron, UPS, and Zebra
Regeneron (REGN) has seemingly overcome its bear phase, with shares rising by 12% to over $650 after reporting a 0.8% increase in revenue to $3.75 billion.
- Strong sales of Dupixent, totaling $4.9 billion, offset weak sales from EYLEA.
- EYLEA HD sales grew by 42% to $663 million.
- The firm lowered its R&D and SG&A expense forecast for the fiscal year.
UPS, despite being down nearly 25% in 2025, added 8.0% after posting non-GAAP EPS of $1.74 on revenue of $21.4 billion (-3.6% Y/Y).
Stock markets rallied after the firm announced a massive 48,000 job cut, with 34,000 job cuts in the operational unit and 14,000 roles cut at the management level.
Zebra (ZBRA) continued its downtrend, which began in August and accelerated in October, with the stock losing 11%.
Author's summary: Stocks show mixed results amidst earnings reports.
More News
- Benin coup attempt foiled by loyalist troops, interior minister says
- Benin: the government declares coup attempt has been 'foiled'
- Cheap Domestic Flights in United States of America
- Delegates delayed at Brynglas Tunnels is Drakeford's fault
- Full steam ahead for good causes at train station's big birthday bash
- Congress gridlocked on key issues as year-end deadline looms
- Another Coup In Africa, Soldiers Appear On State TV To Announce Takeover
- Heavy rain gridlocks KL traffic
- Benin authorities say coup attempt foiled, President Talon safe
- Sydney Sixers Vs Adelaide Strikers, WBBL 2025: SYS-W Beat AS-W By One Run Thanks To Ellyse Perry Century